IBA’s Quality Policy aims to exceed our customer’s expectations in all service provisions (projects, post-project support and production center operation). This will be accomplished by understanding and focusing-on performance measures that are critical to our customer’s success. The primary indicators for monitoring our performance and establishing targets for continuous improvements shall focus on:

• The effectiveness of product development and project management processes, according to the best practices from industry standards and involving all partners,
• On-time and quality-compliant customer deliveries based on established lead times,
• The number, timeliness and quality of response to critical quality issues; raised either internally or externally,
• The effective application of the GxP standards for medicinal products and all equipment used for pharmaceutical production.

The Management of IBA and its subsidiaries will drive continual improvement and innovation based upon efficient business processes, well-defined measurements, best practices, observations resulting from audits and customer surveys. They will also promote teamwork and use of a common business language (English in addition to local requirements), terminology and processes.

The management of IBA and its subsidiaries shall ensure that for each department or business unit, a Quality Management System is established and maintained, which meets or exceeds applicable regulatory requirements and conforms to the rules, goals and requirements of the current Regulatory Affairs and Qualtity, Environment, Health and Safety Management Policy Manual.